CA2723871A1 - Process for the synthesis of .gamma. -amino acids - Google Patents

Process for the synthesis of .gamma. -amino acids Download PDF

Info

Publication number
CA2723871A1
CA2723871A1 CA2723871A CA2723871A CA2723871A1 CA 2723871 A1 CA2723871 A1 CA 2723871A1 CA 2723871 A CA2723871 A CA 2723871A CA 2723871 A CA2723871 A CA 2723871A CA 2723871 A1 CA2723871 A1 CA 2723871A1
Authority
CA
Canada
Prior art keywords
process according
group
pregabalin
methyl
gamma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2723871A
Other languages
English (en)
French (fr)
Inventor
Vinayak Gore
Maheshkumar Gadakar
Dattatreya Shinde
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Generics UK Ltd
Original Assignee
Generics UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Generics UK Ltd filed Critical Generics UK Ltd
Publication of CA2723871A1 publication Critical patent/CA2723871A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04—Formation of amino groups in compounds containing carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C07C201/06—Preparation of nitro compounds
    • C07C201/12—Preparation of nitro compounds by reactions not involving the formation of nitro groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CA2723871A 2008-06-03 2009-06-03 Process for the synthesis of .gamma. -amino acids Abandoned CA2723871A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN985/KOL/2008 2008-06-03
IN985KO2008 2008-06-03
PCT/GB2009/050612 WO2009147434A1 (en) 2008-06-03 2009-06-03 A novel and efficient method for the synthesis of an amino acid

Publications (1)

Publication Number Publication Date
CA2723871A1 true CA2723871A1 (en) 2009-12-10

Family

ID=40999769

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2723871A Abandoned CA2723871A1 (en) 2008-06-03 2009-06-03 Process for the synthesis of .gamma. -amino acids

Country Status (7)

Country Link
US (1) US20110190393A1 (https=)
EP (1) EP2280930A1 (https=)
JP (1) JP2011522027A (https=)
CN (1) CN102112436A (https=)
AU (1) AU2009254931A1 (https=)
CA (1) CA2723871A1 (https=)
WO (1) WO2009147434A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2383255A1 (en) 2010-04-28 2011-11-02 Lacer, S.A. New compounds, synthesis and use thereof in the treatment of pain
CN103193615A (zh) * 2013-03-26 2013-07-10 河北科技大学 5-氯戊酰氯的合成新方法
CN106488906B (zh) * 2014-06-12 2018-10-26 斯福瑞有限公司 β-取代的γ-氨基羧酸的制备方法
JP6704577B2 (ja) * 2015-02-23 2020-06-03 国立大学法人 奈良先端科学技術大学院大学 カーボンナノチューブ−ドーパント組成物複合体の製造方法およびカーボンナノチューブ−ドーパント組成物複合体
US11000541B1 (en) * 2020-05-11 2021-05-11 Donald Richard Wilshe Medicine composition for facilitating treating organs of a mammal

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637767A (en) * 1995-06-07 1997-06-10 Warner-Lambert Company Method of making (S)-3-(aminomethyl)-5-methylhexanoic acid
EP1140793B1 (en) * 1998-12-29 2003-09-24 Richter Gedeon Vegyeszeti Gyar R.T. Process for the synthesis of 1-(aminomethyl)cyclohexyl-acetic acid
HU225502B1 (en) * 1998-12-29 2007-01-29 Richter Gedeon Vegyeszet Process for producing 1-(amino-metyl)-cyclohexene-acetic-acid and intermediates
DE10203122A1 (de) * 2002-01-25 2003-07-31 Gruenenthal Gmbh Verfahren zur Herstellung von substituierten Acrylsäureestern bzw. deren Einsatz zur Herstellung von substituierten gamma-Aminosäuren
EP1768950A2 (en) * 2005-04-11 2007-04-04 Teva Pharmaceutical Industries Ltd. Process for making (s)-pregabalin
CN101362696A (zh) * 2008-09-27 2009-02-11 开原亨泰精细化工厂 3-氨甲基-5-甲基己酸即混旋普瑞巴林的制备新方法

Also Published As

Publication number Publication date
CN102112436A (zh) 2011-06-29
AU2009254931A1 (en) 2009-12-10
US20110190393A1 (en) 2011-08-04
WO2009147434A1 (en) 2009-12-10
JP2011522027A (ja) 2011-07-28
EP2280930A1 (en) 2011-02-09

Similar Documents

Publication Publication Date Title
AU2007274034B2 (en) Process of preparing a gamma-amino acid
US9115052B2 (en) Separation of an enantiomer mixture of (R)- and (S)-3-amino-1-butanol
CA2723871A1 (en) Process for the synthesis of .gamma. -amino acids
KR20120128667A (ko) 라코사미드의 제조방법
CA2710152A1 (en) Processes to pregabalin
CN102712572B (zh) 一种用于获得 3，3-二苯基丙胺的方法
JP2002511445A (ja) キラル（ｓ）−２，３−二置換−１−プロピルアミン誘導体の製造方法
CA2731165A1 (en) Process for the preparation of o-desmethylvenlafaxine
EP2448916B1 (en) Production of trans-4-aminocyclopent-2-ene-1-carboxylic acid derivatives
CA2724450A1 (en) Method for producing optically active aminoalcohol derivative
JP2016511761A (ja) ４−ピペリジン−４−イル−ベンゼン−１，３−ジオール及びその塩の合成方法、並びに新規化合物ｔｅｒｔ−ブチル４−（２，４−ジヒドロキシ−フェニル）−４−ヒドロキシ−ピペリジン−１−カルボキシレート
US20100168385A1 (en) Process for preparing enantiomerically enriched amino-alcohols
CZ293791B6 (cs) Způsob výroby N,N-diisopropyl-3-(2-hydroxy-5-methylfenyl)-3-fenylpropylaminu v jeho racemické nebo opticky aktivní formě
EP3154930B1 (en) Method for the preparation of beta-substituted gamma-amino carboxylic acids
US7265238B2 (en) Process for preparing methyl 4-(aminomethyl)benzoate
JP3144920B2 (ja) α−アシルアミノケトン誘導体、その製造方法及びその利用
JP3144921B2 (ja) ベンジルエステル誘導体及びその製造方法
EA016854B1 (ru) Новый способ получения эфира 3-амино-5-фтор-4-диалкоксипентановой кислоты
JP2000044521A (ja) α―位に第三級炭化水素基を有するアミノ酢酸エステルの製造方法
JPH0912545A (ja) ６−アミノ−３−アザビシクロ［３．１．０］ヘキサン誘導体の製造方法
JPS61155354A (ja) β−ケトエステル類の不斉還元方法

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20131115